Exon skip ID | chr | Exons involved in exon skipping | Skipped exon |
exon_skip_112666 | chr19 | 3668404:3668440:3669673:3669904:3700297:3700390 | 3669673:3669904 |
exon_skip_124949 | chr19 | 3647338:3647386:3648625:3648708:3651826:3652031 | 3648625:3648708 |
exon_skip_176063 | chr19 | 3641705:3641809:3642907:3642939:3643243:3643381 | 3642907:3642939 |
exon_skip_187868 | chr19 | 3661930:3662001:3664857:3664914:3667322:3667344 | 3664857:3664914 |
exon_skip_206481 | chr19 | 3643243:3643381:3644087:3644251:3645974:3646058 | 3644087:3644251 |
exon_skip_22139 | chr19 | 3632876:3633169:3633437:3633520:3638884:3639016 | 3633437:3633520 |
exon_skip_294421 | chr19 | 3661930:3662001:3664822:3664914:3667322:3667344 | 3664822:3664914 |
exon_skip_42845 | chr19 | 3633113:3633169:3633437:3633520:3638884:3639016 | 3633437:3633520 |
exon_skip_6536 | chr19 | 3643249:3643381:3644087:3644251:3645974:3646058 | 3644087:3644251 |
exon_skip_72313 | chr19 | 3644089:3644251:3645974:3646058:3647338:3647386 | 3645974:3646058 |
UniProt acc. | Start of exon skipping (AA) | End of exon skipping (AA) | Protein feature start (AA) | Protein feature end (AA) | Category of protein feature | Description of feature |
O60331 | 42 | 72 | 1 | 668 | Chain | ID=PRO_0000185462;Note=Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma |
O60331 | 376 | 403 | 1 | 668 | Chain | ID=PRO_0000185462;Note=Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma |
O60331 | 376 | 403 | 75 | 443 | Domain | Note=PIPK;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00781 |
O60331 | 448 | 503 | 1 | 668 | Chain | ID=PRO_0000185462;Note=Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma |
O60331 | 448 | 503 | 459 | 459 | Modified residue | Note=Asymmetric dimethylarginine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O70161 |
O60331 | 448 | 503 | 459 | 459 | Modified residue | Note=Omega-N-methylarginine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O70161 |
O60331 | 550 | 560 | 1 | 668 | Chain | ID=PRO_0000185462;Note=Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma |
O60331 | 550 | 560 | 555 | 555 | Modified residue | Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q5I6B8 |
O60331 | 640 | 667 | 640 | 668 | Alternative sequence | ID=VSP_042078;Note=In isoform 2. FPTDERSWVYSPLHYSAQAPPASDGESDT->FWRLWGPHAPTWPWRREGRAACLCPYPPHVVTPFPGTGLCASWSPDGTGGLGAMSCCVSVS;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:19548880;Dbxref=PMID:19548880 |
O60331 | 640 | 667 | 641 | 668 | Alternative sequence | ID=VSP_042080;Note=In isoform 3. PTDERSWVYSPLHYSAQAPPASDGESDT->FTDGRYWIYSPRHRRLRAVTLSASGTVSDRSRPPWGEGAVPLGQQGAAGPRPEAQCLTSVVFQKGFG;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:19548880;Dbxref=PMID:19548880 |
O60331 | 640 | 667 | 641 | 668 | Alternative sequence | ID=VSP_042079;Note=In isoform 4. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039 |
O60331 | 640 | 667 | 1 | 668 | Chain | ID=PRO_0000185462;Note=Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma |
O60331 | 640 | 667 | 644 | 646 | Helix | Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3H1Z |
O60331 | 640 | 667 | 649 | 649 | Modified residue | Note=Phosphotyrosine%3B by CSK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15738269;Dbxref=PMID:15738269 |
O60331 | 640 | 667 | 650 | 650 | Modified residue | Note=Phosphoserine%3B by CDK5%2C MAPK1 and CDK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15738269;Dbxref=PMID:15738269 |
O60331 | 640 | 667 | 662 | 662 | Modified residue | Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O70161 |
O60331 | 640 | 667 | 666 | 666 | Modified residue | Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q5I6B8 |
O60331 | 640 | 667 | 650 | 650 | Mutagenesis | Note=Abolishes binding to TLN2. Affects localization to focal adhesions. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15738269;Dbxref=PMID:15738269 |
O60331 | 640 | 667 | 650 | 650 | Mutagenesis | Note=Does not affect binding to TLN2 and localization to focal adhesions. S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15738269;Dbxref=PMID:15738269 |
O60331 | 640 | 667 | 641 | 668 | Region | Note=Mediates interaction with TLN2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12422219;Dbxref=PMID:12422219 |
UniProt acc. | Start of exon skipping (AA) | End of exon skipping (AA) | Protein feature start (AA) | Protein feature end (AA) | Category of protein feature | Description of feature |
O60331 | 42 | 72 | 1 | 668 | Chain | ID=PRO_0000185462;Note=Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma |
O60331 | 376 | 403 | 1 | 668 | Chain | ID=PRO_0000185462;Note=Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma |
O60331 | 376 | 403 | 75 | 443 | Domain | Note=PIPK;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00781 |
O60331 | 550 | 560 | 1 | 668 | Chain | ID=PRO_0000185462;Note=Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma |
O60331 | 550 | 560 | 555 | 555 | Modified residue | Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q5I6B8 |
O60331 | 640 | 667 | 640 | 668 | Alternative sequence | ID=VSP_042078;Note=In isoform 2. FPTDERSWVYSPLHYSAQAPPASDGESDT->FWRLWGPHAPTWPWRREGRAACLCPYPPHVVTPFPGTGLCASWSPDGTGGLGAMSCCVSVS;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:19548880;Dbxref=PMID:19548880 |
O60331 | 640 | 667 | 641 | 668 | Alternative sequence | ID=VSP_042080;Note=In isoform 3. PTDERSWVYSPLHYSAQAPPASDGESDT->FTDGRYWIYSPRHRRLRAVTLSASGTVSDRSRPPWGEGAVPLGQQGAAGPRPEAQCLTSVVFQKGFG;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:19548880;Dbxref=PMID:19548880 |
O60331 | 640 | 667 | 641 | 668 | Alternative sequence | ID=VSP_042079;Note=In isoform 4. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039 |
O60331 | 640 | 667 | 1 | 668 | Chain | ID=PRO_0000185462;Note=Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma |
O60331 | 640 | 667 | 644 | 646 | Helix | Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3H1Z |
O60331 | 640 | 667 | 649 | 649 | Modified residue | Note=Phosphotyrosine%3B by CSK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15738269;Dbxref=PMID:15738269 |
O60331 | 640 | 667 | 650 | 650 | Modified residue | Note=Phosphoserine%3B by CDK5%2C MAPK1 and CDK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15738269;Dbxref=PMID:15738269 |
O60331 | 640 | 667 | 662 | 662 | Modified residue | Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O70161 |
O60331 | 640 | 667 | 666 | 666 | Modified residue | Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q5I6B8 |
O60331 | 640 | 667 | 650 | 650 | Mutagenesis | Note=Abolishes binding to TLN2. Affects localization to focal adhesions. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15738269;Dbxref=PMID:15738269 |
O60331 | 640 | 667 | 650 | 650 | Mutagenesis | Note=Does not affect binding to TLN2 and localization to focal adhesions. S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15738269;Dbxref=PMID:15738269 |
O60331 | 640 | 667 | 641 | 668 | Region | Note=Mediates interaction with TLN2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12422219;Dbxref=PMID:12422219 |
UniProt acc. | Start of exon skipping (AA) | End of exon skipping (AA) | Protein feature start (AA) | Protein feature end (AA) | Category of protein feature | Description of feature |
O60331 | 42 | 72 | 1 | 668 | Chain | ID=PRO_0000185462;Note=Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma |
O60331 | 376 | 403 | 1 | 668 | Chain | ID=PRO_0000185462;Note=Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma |
O60331 | 376 | 403 | 75 | 443 | Domain | Note=PIPK;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00781 |
O60331 | 448 | 503 | 1 | 668 | Chain | ID=PRO_0000185462;Note=Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma |
O60331 | 448 | 503 | 459 | 459 | Modified residue | Note=Asymmetric dimethylarginine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O70161 |
O60331 | 448 | 503 | 459 | 459 | Modified residue | Note=Omega-N-methylarginine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O70161 |
O60331 | 550 | 560 | 1 | 668 | Chain | ID=PRO_0000185462;Note=Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma |
O60331 | 550 | 560 | 555 | 555 | Modified residue | Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q5I6B8 |
O60331 | 640 | 667 | 640 | 668 | Alternative sequence | ID=VSP_042078;Note=In isoform 2. FPTDERSWVYSPLHYSAQAPPASDGESDT->FWRLWGPHAPTWPWRREGRAACLCPYPPHVVTPFPGTGLCASWSPDGTGGLGAMSCCVSVS;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:19548880;Dbxref=PMID:19548880 |
O60331 | 640 | 667 | 641 | 668 | Alternative sequence | ID=VSP_042080;Note=In isoform 3. PTDERSWVYSPLHYSAQAPPASDGESDT->FTDGRYWIYSPRHRRLRAVTLSASGTVSDRSRPPWGEGAVPLGQQGAAGPRPEAQCLTSVVFQKGFG;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:19548880;Dbxref=PMID:19548880 |
O60331 | 640 | 667 | 641 | 668 | Alternative sequence | ID=VSP_042079;Note=In isoform 4. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039 |
O60331 | 640 | 667 | 1 | 668 | Chain | ID=PRO_0000185462;Note=Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma |
O60331 | 640 | 667 | 644 | 646 | Helix | Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3H1Z |
O60331 | 640 | 667 | 649 | 649 | Modified residue | Note=Phosphotyrosine%3B by CSK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15738269;Dbxref=PMID:15738269 |
O60331 | 640 | 667 | 650 | 650 | Modified residue | Note=Phosphoserine%3B by CDK5%2C MAPK1 and CDK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15738269;Dbxref=PMID:15738269 |
O60331 | 640 | 667 | 662 | 662 | Modified residue | Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O70161 |
O60331 | 640 | 667 | 666 | 666 | Modified residue | Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q5I6B8 |
O60331 | 640 | 667 | 650 | 650 | Mutagenesis | Note=Abolishes binding to TLN2. Affects localization to focal adhesions. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15738269;Dbxref=PMID:15738269 |
O60331 | 640 | 667 | 650 | 650 | Mutagenesis | Note=Does not affect binding to TLN2 and localization to focal adhesions. S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15738269;Dbxref=PMID:15738269 |
O60331 | 640 | 667 | 641 | 668 | Region | Note=Mediates interaction with TLN2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12422219;Dbxref=PMID:12422219 |